drugset / Trial / NCT00095914
Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1
Completed
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Drugs used in chemotherapy, such as paclitaxel and ABI-007, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining paclitaxel with ABI-007 may kill more tumor cells. PURPOSE: Randomized phase I trial to study the effectiveness of combining paclitaxel with ABI-007 in treating patients who have locally advanced or metastatic solid tumors.
Timeline
- Start
- 2004-09
- Primary completion
- 2007-05
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABI-007 | Unknown | — | — |
| Subject | Paclitaxel | Small molecule | — | Intravenous |